As an Australian Hemp Company, our mission is to improve the lives of individuals and families globally, through providing access to high quality, therapeutic, plant-based cannabinoid products.
SEED-TO-SHELF QUALITY PROCESS:
Ananda Hemp controls the entire process of production from seed to shelf, which includes over 30+ quality check points to ensure quality and safety of all products for patients. Every batch is 3rd party tested for quality, potency, solvents. pesticides. microbials and heavy metals to provide full transparency to patients and their doctors.
ANANDA PRODUCT OVERVIEW
Ananda Hemp Full Spectrum 2000mg (50 ml)
40mg Cannabidiol (CBD) per 1 ml of Tincture <0.3% delta-9 tetrahydrocannabinol (THC) per 1 ml of Tincture
INGREDIENTS: Ananda Full Spectrum Hemp Extract. 100% Australian Cold Pressed Hemp Seed Oil, MCT Oil, Terpene Blend
PHYSICAL DESCRIPTION: Golden liquid in tincture with earthy herbal flavour.
RECOMMENDED INITIAL START DOSE: 10mg per day (0.25 ml liquid). unless otherwise perscribed by your doctor.
HOW TO ADMINISTER: Take orally via dropper provided for liquid and hold under the tongue for 60 seconds.
Ananda Hemp 900mg Full Spectrum Soft Gels (60ct)
15mg Cannabidiol (CBD) per capsule <0.3% delta-9 tetrahydrocannabinol (THC) per capsule
INGREDIENTS: Ananda Full Spectrum Hemp Extract. 100% Australian Cold Pressed Hemp Seed Oil, Gelatin, Glycerin
PHYSICAL DESCRIPTION: Golden liquid in tincture with earthy herbal flavour.
RECOMMENDED INITIAL START DOSE One 15mg gel cap per day, unless otherwise prescribed by your doctor.
HOW TO ADMINISTER: Take orally by swallowing capsules.
- Start low and go slow to find optimal dose as per recommended by your doctor.
- Recommended initial start dose is 10mg tincture or 1x 15mg gel cap. Titrate up every 3 days until optimal therapeutic benefit is achieved.
- If adverse effects such as dizziness, fatigue or somnolence occur, consider reducing dose or maintaining dose to monitor symptoms with your medical practitioner.
SIDE EFFECTS: Side effects are rare (<10%) but may include somnolence, diarrhoea, heartburn, sleep disturbances, dizziness, rash, dry mouth, and change in appetite. It is unlikely but possible that the limited amount (<0.3%) of THC in the product may cause psychotropic and anticholinergic effects.
WARNINGS: Possession without authority is illegal. Keep out of reach of children. These medications are not TGA registered medicines and Ananda Hemp is only available by authorised prescribers (AP) and Special Access Scheme pathway (SAS-B).
STORAGE: Store at room temp out of direct sunlight (16-24° C). Store closed.
DISPOSAL: Any unused medicine or medicine past its used by date needs to be returned to the pharmacy. Do not dispose in household waste.
WHEN TO CALL DOCTOR: Call a doctor if you experience shortness of breath, difficulty breathing, rapid or change in heart rate, swelling of the throat, tongue, or face, or if you develop a rash.
BACKGROUND EDUCATION
Full Spectrum hemp is a cannabidiol (CBD) rich extract derived from the fiower of the cannabis sativa hemp plant. Full Spectrum means that in addition to CBD, the extract contains other phytocompounds naturally found in the hemp plant. One compound that is always included in Full Spectrum Hemp is THC, or tetrahydrocannabinol. THC is intoxicating in high doses, but it is found in very low concentrations of 0.3% or less in Ananda Hemp extracts.
Ananda Hemp Full Spectrum Extract may have been prescribed to treat symptoms associated with many health conditions, including pain (neuropathic pain, osteoarthritis pain, mixed pain, etc.), insom nia, anxiety, MS or Parkinson's Disease related pain, spasticity or rigidity, seizure disorders, autoimmune disorders such as IBD, rheumatoid arthritis or psoriasis, muscle aches, and more. Ask your doctor if you have any questions about why this medicine has been recommended for you. Your doctor may have recommended it for another reason.
CLINICAL TRIALS FOR ANANDA HEMP EXTRACT:
Ananda Hemp Extracts have been used in an open-label prospective study evaluating their effects on opioid use, chronic pain, and sleep quality among a single cohort of chronic pain patients.
- CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY AMONG BREAST, COLON, UTERINE, AND OVARIAN CANCER PATIENTS
- AGITATION IN ALZHEIMER'S DEMENTIA PATIENTS
- SLEEP DISTURBANCES
- LESION PROLIFERATION AND INNERVATION ON WOMEN WITH ENDOMETRIOSIS